InvestorsHub Logo

Don'tDrinkTheKoolAid

01/29/07 8:18 AM

#55363 RE: stockhlder101 #55359

IS this what your trying to say? U better read it again.

Both Gomez and DNAPrint Genomics will also be part of a massive research initiative announced last month by the H. Lee Moffitt Cancer Center & Research Institute of Tampa. The center said it would partner with an affiliate of Merck & Co., Inc. pharmaceutical company to expand biotechnology research with the goal of developing personalized medicine.

Merck and Moffitt will form a for-profit company, called M2GEN, that will develop personalized cancer treatments using a patient's genetic profile.

Researchers plan to compile a database of tumor tissue and other medical information to determine why some patients respond to a treatment and others do not. The database could grow to more than 30,000 patients within five years, officials said in announcing the partnership.

"For a look at future, in 10 years, I believe you'll have (something similar to) a credit card in your pocket with all your information. It's your genetic makeup and the doctor will look at it and prescribe the medicine for you," said Gomez. "We are very excited about this."

DNAPrint Genomics was founded by Tony Frudakis, Ph.D., and acquired by another company in 2000. In 2001, Frudakis teamed with other scientists to develop new genomics products with consumer, forensic and pharmaco-genomics applications, according to Securities and Exchange Commission documents.

Since then, the company has acquired several other firms that brought scientific assets with them, such as Kenna Technologic Inc., which develops software for building computer models that mimic biological systems, and Ellipsis Biotherapeutics Corp., which specializes in genotyping and can analyze human, plant and animal tissue, SEC documents said.

Last year, the company entered into an exclusive license agreement with Harvard College at Harvard Medical School, for research and development of a diagnostic test that would identify those at risk of developing vascular diabetic complications, SEC documents reported.



M O R E N E W S F R O M
• Genetics
• Life
• Media
• Radio
• Genealogy
• Hobbies
• Manatee County, FL
• Biology
• Science
• California, PA
• Sarasota, FL
• Discuss Sarasota, FL
your tring to say DNAG is part of?

DorseyE

01/29/07 9:18 AM

#55369 RE: stockhlder101 #55359

Quote from the article...

Both Gomez and DNAPrint Genomics will also be part of a massive research initiative announced last month by the H. Lee Moffitt Cancer Center & Research Institute of Tampa. The center said it would partner with an affiliate of Merck & Co., Inc. pharmaceutical company to expand biotechnology research with the goal of developing personalized medicine.

Merck and Moffitt will form a for-profit company, called M2GEN, that will develop personalized cancer treatments using a patient's genetic profile.